LY 225910

CAS : 133040-77-4

Ref. 3D-IFA04077

Informations sur le produit

• Nom: LY 225910
• Synonymes: Ly 225910, 2-(2-(5-Bromo-(1H)-indol-3-yl)ethyl)-3-(3-(1-methylethoxy)phenyl)-4-(3H)-quinazoline, 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]quinazolin-4(3H)-one

Description

LY 225910 is a polymerase chain inhibitor that prevents the formation of new DNA. It has been shown to inhibit the activity of gamma-aminobutyric acid (GABA) in rat model systems and to reduce symptoms of epilepsy. LY 225910 has also been shown to inhibit chelerythrine, an inhibitor of protein kinases, and whole-cell recordings have demonstrated that LY 225910 inhibits cellular physiology by reducing fatty acid metabolism. This drug also binds to bradykinin B2 receptors and neurotrophic factors, such as endocannabinoids, growth factors, and glutamate.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 502.4 g/mol
• Formule: C₂₇H₂₄BrN₃O₂
• Degré de pureté: Min. 95%